Home
/
Conditions
/ Polycystic Ovary Syndrome (PCOS)
Metabolic Health
Schedule a Consultation
Polycystic Ovary Syndrome (PCOS)
PCOS is the most common endocrine disorder in women of reproductive age, yet it is fundamentally misunderstood by the medical system that diagnoses it. It is not primarily an ovarian condition. It is a metabolic and hormonal signaling disorder in which insulin resistance drives androgen excess, disrupts ovulation, and produces the downstream symptoms that define the syndrome. At The Lamkin Clinic, we identify and treat the root cause.
Metabolic HealthHormone OptimizationRoot Cause Treatable
1 in 10women of reproductive age affected by PCOS
70%+of PCOS patients have underlying insulin resistance
Reversiblewith targeted metabolic and hormonal intervention
← Back to Conditions
Condition: Polycystic Ovary Syndrome (PCOS) | Category: Metabolic Health | Reviewed by: Brian Lamkin, DO
What Is Polycystic Ovary Syndrome (PCOS)?
Polycystic ovary syndrome is a complex endocrine condition characterized by a combination of androgen excess, ovulatory dysfunction, and metabolic disruption. Despite its name, the presence of ovarian cysts is neither required for diagnosis nor central to the underlying pathology. The Rotterdam criteria require two of three features: clinical or biochemical hyperandrogenism, oligo-ovulation or anovulation, and polycystic ovarian morphology on ultrasound.
The upstream mechanism in the majority of PCOS patients is insulin resistance. Chronically elevated insulin stimulates the ovarian theca cells to produce excess testosterone, suppresses SHBG production from the liver, and amplifies the LH-to-FSH ratio that disrupts normal follicular development and ovulation. This insulin-driven androgen excess model explains why metabolic intervention is the most effective long-term treatment for most PCOS presentations.
Key principle: PCOS is not an ovarian disease. It is a metabolic and hormonal signaling disorder in which insulin resistance is the upstream driver in more than 70% of cases. Treating the ovarian symptoms without addressing the metabolic root cause produces suppression, not resolution.
Why It Matters
Metabolic and Cardiovascular Risk
- Women with PCOS are four to seven times more likely to develop type 2 diabetes than age-matched controls
- The full cardiovascular risk cluster including elevated triglycerides, low HDL, small dense LDL, hypertension, and elevated hs-CRP is present even in lean PCOS patients
- Non-alcoholic fatty liver disease is significantly more prevalent in PCOS, driven by the same insulin resistance mechanism
- Endometrial cancer risk is elevated from chronic unopposed estrogen exposure in anovulatory cycles
Reproductive and Psychological Impact
- Anovulation from PCOS is one of the most common causes of infertility and is frequently treatable through metabolic intervention alone
- Depression and anxiety are two to three times more prevalent driven by hormonal disruption, insulin-mediated neurotransmitter effects, and psychosocial burden
- Acne, hirsutism, and hair thinning from androgen excess produce significant quality-of-life impact
- Addressing the metabolic root cause frequently improves both reproductive and psychological outcomes simultaneously
Common Symptoms
Reproductive and Menstrual
- Irregular menstrual cycles longer than 35 days or fewer than 8 cycles per year
- Absent periods for three or more consecutive months
- Difficulty conceiving or recurrent early pregnancy loss
- Heavy or prolonged bleeding from anovulatory cycles
Androgenic Signs
- Jawline and chin acne unresponsive to topical treatment
- Excess hair growth on face, chest, abdomen, or back
- Thinning hair at the crown or temples
- Oily skin persisting beyond adolescence
Metabolic Signals
- Abdominal weight gain despite dietary effort
- Sugar and carbohydrate cravings from insulin dysregulation
- Fatigue and brain fog, particularly after meals
- Skin tags and acanthosis nigricans, clinical signs of hyperinsulinemia
Root Causes: A Functional Medicine Perspective
Conventional medicine diagnoses PCOS by its symptoms and manages them with hormonal contraceptives and anti-androgens. Functional medicine identifies the upstream drivers that produce the hormonal cascade in the first place.
Insulin Resistance
The primary metabolic driver in 70 to 80 percent of PCOS patients. Elevated insulin directly stimulates ovarian androgen production, suppresses SHBG, and disrupts the LH/FSH ratio. This mechanism operates independently of body weight, which is why lean women with PCOS can have significant insulin resistance.
Chronic Inflammation
Elevated hs-CRP and inflammatory markers stimulate ovarian androgen production independently of insulin and impair insulin receptor sensitivity, creating a compounding feedback loop. Chronic inflammation from gut dysbiosis, food sensitivities, and environmental toxins is a common trigger.
Adrenal Androgen Excess
Approximately 20 to 30 percent of PCOS patients have elevated DHEA-S from adrenal origin. This pattern is more common in lean phenotypes and is driven by HPA axis dysregulation from chronic stress. Cortisol and DHEA-S testing distinguishes this from the insulin-driven model.
Gut Dysbiosis and Thyroid Dysfunction
The gut microbiome modulates estrogen metabolism and systemic inflammation. Subclinical hypothyroidism and Hashimoto's thyroiditis coexist with PCOS at significantly elevated rates, worsening insulin resistance and disrupting menstrual cyclicity independently.
Conventional vs Functional Medicine Approach
| Domain | Conventional Medicine | Functional Medicine |
|---|---|---|
| Diagnosis | Rotterdam criteria; prescribes oral contraceptives to regulate cycles | Identifies the specific PCOS phenotype (insulin-driven, inflammatory, adrenal, or mixed) |
| Androgen management | Spironolactone or anti-androgens for acne and hirsutism | Reduces androgens by lowering insulin, improving SHBG, and addressing adrenal or inflammatory contributors |
| Fertility | Refers to reproductive endocrinology without metabolic workup | Restores ovulation by reversing the metabolic environment; many patients conceive without assisted reproduction |
| Testing | Rarely tests fasting insulin, HOMA-IR, or inflammatory markers | Full metabolic and hormonal panel: fasting insulin, HOMA-IR, SHBG, DHEA-S, testosterone, hs-CRP, thyroid panel |
Key Labs to Evaluate
A comprehensive PCOS evaluation requires both metabolic and hormonal testing. The standard workup of total testosterone and ultrasound is insufficient to identify the specific driver or guide treatment selection.
Fasting InsulinThe earliest marker of insulin-driven PCOS. Functional target below 5 uIU/mL.
→SHBGFalls in direct response to insulin resistance. Low SHBG confirms metabolic PCOS.
→DHEA-SIdentifies adrenal-origin androgen excess versus ovarian-driven PCOS.
→hs-CRPInflammatory burden compounding insulin resistance and androgen pathways.
→Free TestosteroneDirect measure of bioavailable androgen excess driving PCOS symptoms.
→How to Interpret These Labs Together
Elevated fasting insulin with low SHBG and elevated free testosterone confirms insulin-driven ovarian androgen excess. A patient with normal insulin, normal SHBG, and elevated DHEA-S has adrenal-origin hyperandrogenism. These two patients carry the same diagnostic label but require fundamentally different treatment strategies.
SHBG is one of the most underutilized markers in PCOS evaluation. It falls in direct response to insulin resistance and is often the earliest measurable hormonal consequence of metabolic dysfunction, even when fasting glucose and HbA1c are normal.
Elevated hs-CRP alongside insulin resistance identifies the inflammatory compounding pattern that requires anti-inflammatory intervention in addition to metabolic treatment.
Common Patterns Seen in Patients
- "I was put on birth control at 16 and never investigated further": A 32-year-old woman diagnosed with PCOS as a teenager. Stopped the pill to conceive; periods did not return. Fasting insulin 18, HOMA-IR 4.1, SHBG 14 nmol/L. Entirely insulin-driven. Metabolic intervention restored spontaneous ovulation within 4 months.
- Lean PCOS dismissed because of normal BMI: A 28-year-old woman with irregular periods, jawline acne, and anxiety. BMI 22. Fasting insulin 12, DHEA-S elevated, hs-CRP 3.2 mg/L. Adrenal-origin androgen excess with inflammatory compounding, a weight-independent phenotype.
- Spironolactone for acne without metabolic workup: Acne improved but gained 12 pounds with worsening fatigue and persistent irregular periods. Fasting insulin 22 uIU/mL. Spironolactone managed a symptom while underlying insulin resistance continued to drive weight gain and ovulatory failure.
- Weight loss resistance despite extreme restriction: Eating 1,200 calories daily, exercising five days per week, no weight loss. Fasting insulin 19 uIU/mL. Chronically elevated insulin suppresses fat oxidation regardless of caloric deficit. Reducing insulin through carbohydrate quality modification allowed weight loss within 6 weeks.
Treatment and Optimization Strategy
Metabolic Foundation
Reducing insulin is the single highest-leverage intervention for insulin-driven PCOS. Carbohydrate quality modification, time-restricted eating, and progressive resistance training form the foundation. The target is metabolic normalization, not caloric restriction.
Metabolic Intervention
- Inositol supplementation (myo-inositol 4g and D-chiro-inositol 100mg daily); improves insulin sensitivity, reduces androgens, and improves ovulation rates
- Berberine 500mg twice daily for AMPK activation comparable to metformin; also improves gut microbiome composition
- Magnesium and omega-3 fatty acids for insulin receptor signaling and anti-inflammatory support
- Time-restricted eating (8 to 10 hour window) to lower total daily insulin exposure
Hormonal Restoration
- As insulin falls, SHBG rises and free testosterone normalizes; ovulatory cycles frequently resume without medication
- HPA axis support for adrenal-origin PCOS through stress management, adaptogens, and sleep optimization
- Anti-inflammatory protocols including gut permeability repair and food sensitivity elimination
- Thyroid optimization when concurrent thyroid dysfunction is identified
What Most Doctors Miss
- Not testing fasting insulin: the insulin resistance driving PCOS is invisible without it. A normal fasting glucose and HbA1c do not rule out significant insulin resistance.
- Treating PCOS as a gynecological condition: oral contraceptives suppress ovulation rather than fix the hormonal environment. The same metabolic dysfunction returns when the pill is discontinued, often worse.
- Not phenotyping PCOS: insulin-driven, adrenal-driven, inflammatory, and post-pill PCOS have different mechanisms and require different interventions.
- Dismissing lean PCOS: insulin resistance operates independently of BMI. Lean PCOS patients have the same cardiovascular and metabolic risk as obese PCOS patients.
When to Seek Medical Care
If you experience irregular or absent periods, jawline acne unresponsive to topical treatment, excess facial or body hair, difficulty losing weight, hair thinning, or difficulty conceiving, a comprehensive metabolic and hormonal evaluation is warranted. This is especially important if you have been prescribed oral contraceptives or spironolactone without a metabolic workup.
At The Lamkin Clinic, PCOS evaluation includes fasting insulin, HOMA-IR, SHBG, free and total testosterone, DHEA-S, hs-CRP, thyroid markers, and additional tests guided by clinical presentation.
Recommended Testing
PCOS evaluation requires both hormonal and metabolic testing. Standard screening with total testosterone and ultrasound is insufficient for phenotyping or guiding targeted treatment.
Hormonal Assessment
- Free and Total Testosterone
- SHBG
- DHEA-S
- LH and FSH
Metabolic Assessment
- Fasting Insulin
- HOMA-IR
- hs-CRP
- Thyroid Panel
Not sure which testing applies to you?
Explore All Testing Options →Frequently Asked Questions
Can I have PCOS without cysts on my ovaries?
Yes. Polycystic ovarian morphology is only one of three diagnostic criteria and is not required for diagnosis. The condition is defined by androgen excess and ovulatory dysfunction, not by the presence of cysts.
Is PCOS curable?
The underlying metabolic drivers are modifiable and often reversible. When insulin resistance is treated, androgen levels normalize, SHBG rises, and ovulatory function frequently restores. Many patients achieve sustained metabolic normalization and regular cycles without ongoing medication.
Why does my doctor only prescribe birth control for PCOS?
Oral contraceptives regulate the menstrual cycle and suppress androgen levels but achieve this by suppressing ovulation, not by fixing the metabolic environment. They do not address insulin resistance or cardiovascular risk, and the original imbalance returns when discontinued.
Can lean women have insulin-resistant PCOS?
Yes. Insulin resistance in PCOS operates independently of BMI. Lean PCOS patients have higher fasting insulin, lower SHBG, and greater cardiovascular risk than BMI-matched controls without PCOS.
What is the role of inositol in PCOS treatment?
Myo-inositol and D-chiro-inositol are second messengers in the insulin signaling pathway. Supplementation at a 40:1 ratio has been shown to improve insulin sensitivity, reduce androgens, improve ovulation rates, and enhance oocyte quality. It is one of the most evidence-supported natural interventions for insulin-driven PCOS.
How The Lamkin Clinic Approaches PCOS
Clinical Perspective
PCOS is one of the most mismanaged conditions in medicine. The standard approach puts women on birth control at diagnosis, often as teenagers, and never investigates the metabolic mechanism that produced the hormonal disruption. When we run the metabolic panel, the picture becomes immediately clear: elevated insulin, low SHBG, and a metabolic environment that was never addressed. Once we treat the insulin resistance, the hormonal cascade that defined their PCOS frequently resolves on its own.
Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma
At The Lamkin Clinic, PCOS evaluation begins with comprehensive metabolic and hormonal testing to identify the specific phenotype: insulin-driven, adrenal-driven, inflammatory, or mixed. Treatment is built around the dominant mechanism. Medication selection, nutritional strategy, and supplement protocols are matched to the individual lab pattern rather than applied as a generic PCOS protocol.
Related Conditions
Insulin ResistanceThe upstream metabolic driver in 70%+ of PCOS patients
→Metabolic SyndromeThe cardiovascular risk cluster that accompanies insulin-driven PCOS
→Thyroid DysfunctionHashimoto's and hypothyroidism coexist with PCOS at elevated rates
→Adrenal DysfunctionAdrenal androgen excess drives the non-insulin PCOS phenotype
→Estrogen DominanceAnovulatory cycles produce unopposed estrogen increasing endometrial risk
→Female Hormone ImbalanceAndrogen excess and progesterone deficiency as the hormonal expression of PCOS
→Related Symptoms
Chronic FatigueInsulin-driven energy dysregulation and mitochondrial impairment
→Brain FogInsulin resistance impairs cerebral glucose delivery and cognition
→AnxietyTwo to three times more prevalent in PCOS from hormonal disruption
→DyslipidemiaInsulin-driven lipid pattern: high triglycerides, low HDL, small dense LDL
→Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.
PCOS is identifiable, measurable, and treatable at the metabolic level.
The Lamkin Clinic evaluates PCOS with fasting insulin, HOMA-IR, SHBG, DHEA-S, and comprehensive hormonal testing. Schedule a consultation for a root-cause metabolic evaluation.
Schedule a ConsultationMedical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.